The brand name for insulin aspart is Novolog [1]. It is also available under the brand name Fiasp [2].
What is insulin aspart used for?
Insulin aspart is a rapid-acting insulin used to treat type 1 and type 2 diabetes [1]. It helps lower blood glucose levels after meals [1].
How does Novolog work?
Novolog is a rapid-acting analog of human insulin [1]. It is designed to start working quickly, typically within 15 minutes of injection, peak in about 45-90 minutes, and last for 3 to 5 hours [1]. This allows for more precise matching of insulin action to food intake, helping to prevent post-meal high blood sugar [1].
When does Novolog's patent expire?
Patent expiry dates for drugs can be complex and involve multiple patents covering different aspects of the drug, such as formulation, manufacturing, and methods of use [3]. Information on specific patent expiry for Novolog and its generic versions can be found on resources like DrugPatentWatch.com [3].
Can generic versions of Novolog be produced?
Yes, generic versions of insulin aspart have been approved [4]. These generic products are designed to be bioequivalent to the brand-name Novolog, meaning they are expected to have the same safety and effectiveness [4]. The availability of generics can lead to lower costs for patients [4].
What are the differences between Novolog and Fiasp?
Fiasp is also an insulin aspart product, but it contains an added ingredient, niacinamide (vitamin B3), which helps it to be absorbed more quickly into the bloodstream [2]. This can result in an even faster onset of action compared to Novolog [2].
What are the potential side effects of insulin aspart?
The most common side effect of insulin aspart, like all insulins, is low blood sugar (hypoglycemia) [1]. Other potential side effects include injection site reactions (itching, redness, swelling), changes in vision, weight gain, and swelling in the hands or feet [1].
How is insulin aspart administered?
Insulin aspart is administered via subcutaneous injection [1]. It can be injected into the abdomen, thigh, or upper arm [1]. It is important to rotate injection sites to prevent lipodystrophy (changes in fat tissue) [1].
What is the cost of insulin aspart?
The cost of insulin aspart can vary depending on the brand (Novolog, Fiasp, or generic versions), the dosage, insurance coverage, and pharmacy pricing [5]. Patients may experience significant out-of-pocket costs, which can be a concern for managing diabetes [5].
Who manufactures Novolog?
Novolog is manufactured by Novo Nordisk [1].
Sources
1. https://www.drugs.com/novolog.html
2. https://www.drugs.com/fiasp.html
3. https://drugpatentwatch.com/
4. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/insulin-aspart-and-insulin-aspart-protamine-products-information
5. https://diabetes.org/living-with-diabetes/know-your-rights/insulin-affordability-and-access